Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
And now we know more approvals are a matter of time. Nasrat has successfully taken a large ANDA to approval from start to finish.
Likewise! :)
So something to note - on the FDA approvals app, it still doesn’t show yet. Therefore, that means the FDA tips off Elite ahead of time that they’ve been approved before the FDA lists the approval on its website. So now I can stop obsessively checking the app. Lol
Mmhm. And what did I say? They will be approved and it is inevitable. Cheers bud!
This is true. They commonly follow the panel’s recommendations but exceptions have occurred. When is the decision date?
Definitely agree on this. Choppy broader markets.
Same thing I’ve said many times here - If you buy at the bid, according to folks here it’ll show as a “sell”. The HUGE majority of shares I’ve bought in ELTP have been at the bid on slow trading days.
I thought it was closer to 15+ but couldn’t remember the full history. Just went off the FDA and Pain Therapeutics documents you posted showing they filed in 2008.
Remoxy has received at least 3 CRLs to date and has been in development for over 10 years too.
Great argument.
“or maybe one that totally took advantage of its counterpart??”
Riiiiight, since Nasrat has already said this agreement is the most favorable one they’ve entered into yet. Better than Dr. Reddy’s Labs, Valeant, Epic/PuraCap, TAGI, Ascend, Hi Tech Pharmacal, etc. #Tryharder
lol
And how much could you stand to gain? A lot more than 9 cents. Any investment is taking a risk.
Yes the chart shows a decline. No, past performance is not necessarily indicative of future results. You see that disclaimer all over financial documents for good reason.
Lately, Elite has adjusted its focus to include several non-ADF generic products in very large markets. They will be approved, and then they will be launched. Glenmark did $1.25 billion in sales for their FY 2016-2017. They wouldn’t partner with Elite for nothing.
Not to mention SequestOx or the ADF drugs to follow it.
“Under investigation” is a flat out lie, folks.
Hahaha. Just keep bringing those facts.
Slaying that DD. Nice job.
As is mine. Thanks.
Got some inside info? Lol.
Thanks for proving my point, actually. I didn’t include seconds though. It was indeed 2:56P and a 5k trade as I noted.
Wrong, last trade is 5k shares at 2:56P CST. #Facts
It absolutely will add revenue if the PD study is successful and docs begin prescribing this for PD patients.
Nice! Wouldn’t that be quite the positive turn of events for Elite! Solid DD for sure.
Investors care.
They’ll likely have 1-3 of the new ANDAs to launch after approvals, as well as the remaining Mikah/Epic ANDAs over the next 18 months or so. Launch launch launch! $$$
None will be provided because it doesn’t exist.
Well the horse’s mouth would be Pfizer in this case. Lol. I’d love to know the answer myself.
Nice. Haven’t read the transcript yet and must’ve missed that red portion about possibly expanding Glenmark agreement to cover Mikah/Epic drugs. Thanks!
Aye.
Plus, now it looks like we’ll just get a second “line” of Phendimetrazine sales/royalty split with Glenmark, which should happen pretty quickly and easily.
Ouch, spoke too soon!
He said it could be approved “within the next couple of months.” 3rd quarter of the calendar year 2018 which is July to September. This would be the undisclosed pain med with roughly 30M+ IMS sales.
I’m looking for the application.
Bold! I like it.
Does look to be some solid buys/support at .0810 here in the last few mins.
Another quality post! Appreciated as always.
No, it’s like historical fact. Thanks though.
“These would be the two SunGen products, with the potential addition of future approved products. And, to that point...”
And to that point, this has already been done with SunGen. Initial agreement followed by an expansion of additional drug products the two companies will collaborate on. The same could certainly happen with Glenmark to market additional drugs as well, precedent has been set.
Nah it isn’t lol lol
No value placed on their cGMP facility? Lol.
“I am definitely in this for the acquisition as well. FDA Perc response will give some insight as to how soon an acquisition might take place. Acquisition is the only way Nasrat will truly be paid for his efforts.”
This. Agreed.
“Completely refutable”, yet zero actual facts provided to do so. Ok. Lmao.
Great example since there are a plethora of companies in a position to acquire a company with a market cap approaching 1 trillion dollars. /s